A. Tibi

发表

Very low oral doses of vitamin B-12 increase serum concentrations in elderly subjects with food-bound vitamin B-12 malabsorption.

J. Ménard, C. Di Menza, P. Ducimetiere, 2007, The Journal of nutrition.

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma.

L. Capelle, L. Puybasset, M. Sanson, 2006, Neuro-oncology.

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

E. Vicaut, M. Dougados, M. Humbert, 2021, The Lancet Respiratory Medicine.

Effect of intravenous almitrine on intubation or mortality in patients with COVID-19 acute hypoxemic respiratory failure: A multicentre, randomised, double-blind, placebo-controlled trial

J. Payen, P. Kalfon, J. Audibert, 2022, eClinicalMedicine.

Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial

E. Vicaut, S. Taillibert, É. Le Rhun, 2015, Cancer science.

Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma 1

L. Capelle, L. Puybasset, M. Sanson, 2005 .

Effect of Oseltamivir, Zanamivir or Oseltamivir– Zanamivir Combination Treatments on Transmission of Influenza in Households

A. Flahault, F. Tubach, F. Carrat, 2012, Antiviral therapy.

Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial

F. Tubach, C. Leport, B. Lina, 2010, PLoS medicine.

Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised study.

L. Capelle, O. Chinot, P. Metellus, 2017, European journal of cancer.

Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study.

Sarah Zohar, Alexandre Carpentier, Francois Lafitte, 2010, Neuro-oncology.

A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients

H. Dombret, S. Chevret, J. Larghero, 2004, Leukemia.

Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas.

P. Petrow, M. Boubaya, J. Grob, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

How to Improve the Implementation of Academic Clinical Pediatric Trials Involving Drug Therapy? A Qualitative Study of Multiple Stakeholders

F. Brion, C. Alberti, H. Abdoul, 2013, PloS one.

Academic pediatric clinical research: factors associated with study implementation duration

F. Brion, C. Alberti, H. Abdoul, 2016, BMC Medical Research Methodology.

Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group

M. Dougados, M. Humbert, G. Baron, 2022, eClinicalMedicine.

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

E. Vicaut, M. Dougados, M. Humbert, 2021, The Lancet Rheumatology.

Pembrolizumab as first-line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC): Phase 2 results from CARSKIN.

P. Petrow, M. Boubaya, J. Grob, 2019, Journal of Clinical Oncology.

CARSKIN: Pembrolizumab as first line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC).

M. Boubaya, O. Schischmanoff, V. Lévy, 2017 .

Vemurafenib in BRAF Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism

C. Lebbé, M. Resche-Rigon, M. Battistella, 2021 .

Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.

H. Dombret, P. Rousselot, H. de Thé, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined T reatment W ith A rsenic T rioxide a nd A ll-Trans- Retinoic A cid i n P atients W ith R elapsed A cute Promyelocytic L eukemia

P. Rousselot, O. Hermine, C. Chomienne, 2003 .

Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study)

G. Chatellier, P. Menasché, B. Cholley, 2016, Journal of Cardiothoracic Surgery.

Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma-a randomised multicentre trial (ASTER trial). An ANOCEF study.

K. Hoang-Xuan, E. Mandonnet, E. Vicaut, 2019, European journal of cancer.

Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial

S. Chevret, C. Protopopescu, C. Leport, 2017, BMJ Open.

randomized placebo-controlled trial.

V. Enouf, S. Werf, T. Blanchon, 2012 .

Phase II trial of intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma.

O. Chinot, P. Metellus, F. Laigle-Donadey, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical trials: management of investigational products during the coronavirus (COVID-19) pandemic

L. Flet, M. Tching-Sin, A. Tibi, 2020, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Phase I–II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAFV600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism

C. Lebbé, M. Resche-Rigon, M. Battistella, 2021, Clinical Cancer Research.

Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial

F. Tubach, C. Leport, B. Lina, 2010, PLoS Medicine.